BENZOYL PEROXIDE WASH, 5% | Perrigo Benzoyl Peroxide

05:44 EDT 27th August 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Benzoyl Peroxide Wash 2.5%, 5% and 10%

Benzoyl Peroxide Wash 2.5%, 5% and 10% are topical preparations containing benzoyl peroxide as the active ingredient.

Benzoyl Peroxide Wash 2.5%, 5% and 10% each contain: 2.5%, 5% and 10% benzoyl peroxide, respectively, in a lathering base formulated with acrylates copolymer, carbomer homopolymer type C, edetate disodium, glycerin, imidurea, purified water, sodium hydroxide, sodium C14-16 olefin sulfonate. May contain citric acid to adjust pH.

The structural formula of benzoyl peroxide is:

IMAGE 2562e53d-fb83-404a-a011-9e6d9b982be5-01.jpg

The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action, combined with the mild keratolytic effect of benzoyl peroxide is believed to be responsible for its usefulness in acne.

Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine.

Benzoyl Peroxide Wash 2.5%, 5% and 10% are indicated for use in the topical treatment of mild to moderate acne vulgaris. Benzoyl Peroxide Wash 2.5%, 5% and 10% may be used as an adjunct in acne treatment regimens including antibiotics, retinoic acid products, and sulfur/salicylic acid containing preparations.

Benzoyl Peroxide Wash 2.5%, 5% and 10% should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the products.

For external use only. Avoid contact with eyes and mucous membranes. AVOID CONTACT WITH HAIR, FABRICS OR CARPETING AS BENZOYL PEROXIDE WILL CAUSE BLEACHING.

Based upon all available evidence, benzoyl peroxide is not considered to be a carcinogen. However, data from a study using mice known to be highly susceptible to cancer suggest that benzoyl peroxide acts as a tumor promoter. The clinical significance of the findings is not known.

Animal reproduction studies have not been conducted with benzoyl peroxide. It is also not known whether benzoyl peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be given to a pregnant woman only if clearly needed.

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when benzoyl peroxide is administered to a nursing woman.

Safety and effectiveness in children below the age of 12 have not been established.

Contact sensitization reactions are associated with the use of topical benzoyl peroxide products and may be expected to occur in 10 to 25 of 1000 patients. The most frequent adverse reactions associated with benzoyl peroxide use are excessive erythema and peeling which may be expected to occur in 5 of 100 patients. Excessive erythema and peeling most frequently appear during the initial phase of drug use and may normally be controlled by reducing frequency of use.

Shake well before using. It is recommended that therapy be initiated with Benzoyl Peroxide Wash 2.5%, washing the affected areas once a day during the first week, and twice a day thereafter as tolerated. Wet skin areas to be treated; apply Benzoyl Peroxide Wash, work to a full lather, rinse thoroughly and pat dry. Frequency of use should be adjusted to obtain the desired clinical response. Therapy with Benzoyl Peroxide Wash 5% or 10% may be initiated in patients who demonstrate accommodation to Benzoyl Peroxide Wash 2.5%.

Clinically visible improvement will normally occur by the third week of therapy. Maximum lesion reduction may be expected after approximately eight to twelve weeks of drug use. Continuing use of the drug is normally required to maintain a satisfactory clinical response.

Benzoyl Peroxide Wash 2.5%, 5% and 10% are available as follows:

Benzoyl Peroxide Wash 2.5%

8 oz plastic bottle (NDC 45802-907-34)

Benzoyl Peroxide Wash 5%

4 oz plastic bottle (NDC 45802-913-26)

5 oz plastic bottle (NDC 45802-913-01)

8 oz plastic bottle (NDC 45802-913-34)

Benzoyl Peroxide Wash 10%

5 oz plastic bottle (NDC 45802-918-01)

8 oz plastic bottle (NDC 45802-918-34)

Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

Manufactured by

Stiefel Laboratories, Inc.

Research Triangle Park, NC 27709

Distributed By


Allegan, MI 49010 •

Rev. 12/10


: 0V500 RC J3

Rx Only

Benzoyl Peroxide Wash 5%

For Topical Use Only

IMAGE 2562e53d-fb83-404a-a011-9e6d9b982be5-02.jpgIMAGE 2562e53d-fb83-404a-a011-9e6d9b982be5-03.jpg


Perrigo New York Inc

Active Ingredients


Drugs and Medications [422 Associated Drugs and Medications listed on BioPortfolio]

Benzoyl peroxide wash [River’s Edge Pharmaceuticals, LLC]

Benzoyl Peroxide Wash 7% (benzoyl peroxide 7%)

Benzoyl peroxide cleansing [River’s Edge Pharmaceuticals, LLC]

4% Benzoyl Peroxide Cleansing Lotion (benzoyl peroxide 4%)

Benzoyl peroxide [River's Edge Pharmaceuticals, LLC]

5.75% Benzoyl Peroxide Wash

Benzoyl peroxide [Perrigo New York Inc]

Benzoyl Peroxide Wash 2.5%, 5% and 10%

Benzoyl peroxide [Perrigo New York Inc]

Benzoyl Peroxide Wash 2.5%, 5% and 10%

Clinical Trials [66 Associated Clinical Trials listed on BioPortfolio]

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel ...

Study to Compare the Tolerance of Clindamycin 1% and Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2% and BPO 2.5% Topical Acne Medications

This is a single-blind (blinded expert grader) study that will enroll 25-30 healthy volunteers without facial acne. On 1 side of the face, the subject will apply 1 of the 2 test products,...

A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions

5 Day study to assess how quickly a topical acne product begins to work.

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Multi-center, single-blind, randomized, comparative, split-face study. The duration of the study is 8 weeks. Commencing at baseline, subjects will apply once daily both clindamycin and be...

Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris

The purpose of this study is to compare the efficacy of a benzoyl peroxide 2.5% cream formulation plus a moisturizing lotion versus benzoyl peroxide 2.5% cream alone for the treatment of a...

PubMed Articles [486 Associated PubMed Articles listed on BioPortfolio]

Bi(OTf)3 Mediated exo-Olefin Isomerization of α-Benzoyl β-Styrylsulfones.

Bi(OTf)3-mediated stereoselective exo-olefin isomerization of α-benzoyl β-styrylsulfones 5 in MeNO2 afforded α-benzoyl α-cinnamylsulfones 6 in moderate to good yields.

Effect of temperature and concentration on benzoyl peroxide bleaching efficacy and benzoic acid levels in whey protein concentrate.

Much of the fluid whey produced in the United States is a by-product of Cheddar cheese manufacture and must be bleached. Benzoyl peroxide (BP) is currently 1 of only 2 legal chemical bleaching agents ...

Multicenter study for efficacy and safety evaluation of a fixeddose combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo® for the treatment of acne vulgaris in Brazilian population.

The current options for the treatment of acne vulgaris present many mechanisms of action. For several times, dermatologists try topical agents combinations, looking for better results.

Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.

Acne vulgaris is commonplace and can be difficult to manage. Providing an effective and well-tolerated treatment may lead to improved adherence, increased patient satisfaction, and improved clinical o...

Metal-free Radical Oxidative Annulation of Ynones with Alkanes to Access Indenones.

The benzoyl peroxide (BPO)-promoted carboannulation of ynones with alkanes is developed, affording a series of 2-alkyl-3-aryl indenones in moderate to good yields. The procedure undergoes direct funct...

Quick Search

Relevant Topics

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record